Alnylam Pharmace. buy BMO Capital Markets
Start price
27.03.24
/
50%
€141.40
Target price
27.03.25
€216.31
Performance (%)
74.96%
End price
28.03.25
€247.40
Summary
This prediction ended on 28.03.25 with a price of €247.40. With a performance of 74.96% the BUY prediction by BMO_Capital_Markets was a big success. BMO_Capital_Markets has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. BMO_Capital_Markets has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -13.930% | -13.930% | 45.011% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by BMO_Capital_Markets for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $234.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€279.80
24.06.25
24.06.25
€310.57
24.06.26
24.06.26
21.02%
12.12.25
12.12.25
Stopped prediction by BMO_Capital_Markets for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€386.00
05.09.25
05.09.25
€402.93
05.09.26
05.09.26
-12.28%
12.12.25
12.12.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€210.70
24.06.24
24.06.24
€218.11
24.06.25
24.06.25
32.04%
25.06.25
25.06.25